Cargando…

Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows

BACKGROUND: Procalcitonin (proCt) was recently proposed as an alternative or in addition to calcitonin (Ct) in medullary thyroid cancer (MTC) diagnostics. METHODS: Serum basal Ct (bCt) and proCt (bproCt) levels were measured before surgery from a consecutive series of patients with (n=43) and withou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Censi, Simona, Di Stefano, Marta, Repaci, Andrea, Benvenuti, Teresa, Manso, Jacopo, Pagotto, Uberto, Iacobone, Maurizio, Barollo, Susi, Bertazza, Loris, Galuppini, Francesca, Benna, Clara, Pennelli, Gianmaria, Plebani, Mario, Faggian, Diego, Colombo, Carla, Fugazzola, Laura, Mian, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548712/ https://www.ncbi.nlm.nih.gov/pubmed/34721303 http://dx.doi.org/10.3389/fendo.2021.754565

Ejemplares similares

Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
por: Censi, Simona, et al.
Publicado: (2021)

Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
por: Cavedon, Elisabetta, et al.
Publicado: (2017)

Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients
por: Pezzani, Raffaele, et al.
Publicado: (2019)

Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden
por: Manso, Jacopo, et al.
Publicado: (2020)

The role of the size in thyroid cancer risk stratification
por: Vianello, Federica, et al.
Publicado: (2021)

Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario
por: Galuppini, Francesca, et al.
Publicado: (2019)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers
por: Mondin, Alberto, et al.
Publicado: (2023)

Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit
por: Censi, Simona, et al.
Publicado: (2017)

Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications
por: Manso, Jacopo, et al.
Publicado: (2022)

MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives
por: Galuppini, Francesca, et al.
Publicado: (2021)

The role of procalcitonin in the follow-up of medullary thyroid cancer
por: Censi, Simona, et al.
Publicado: (2022)

Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
por: Fugazzola, L., et al.
Publicado: (2020)

Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells
por: Bertazza, Loris, et al.
Publicado: (2015)

Prophylactic and Early Thyroidectomy in RET Germline Mutation Carriers in Pediatric and Adult Population: Long-Term Outcomes of a Series of 63 Patients
por: Torresan, Francesca, et al.
Publicado: (2022)

Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma
por: Galuppini, Francesca, et al.
Publicado: (2019)

Changing Dietary Habits in Veneto Region over Two Decades: Still a Long Road to Go to Reach an Iodine-Sufficient Status
por: Censi, Simona, et al.
Publicado: (2020)

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling
por: Galuppini, Francesca, et al.
Publicado: (2022)

The Effects of Iodine Supplementation in Pregnancy on Iodine Status, Thyroglobulin Levels and Thyroid Function Parameters: Results from a Randomized Controlled Clinical Trial in a Mild-to-Moderate Iodine Deficiency Area
por: Censi, Simona, et al.
Publicado: (2019)

A constitutive active MAPK/ERK pathway due to BRAF(V600E) positively regulates AHR pathway in PTC
por: Occhi, Gianluca, et al.
Publicado: (2015)

Circulating miR-146a predicts glucocorticoid response in thyroid eye disease
por: Manso, Jacopo, et al.
Publicado: (2023)

Medullary Thyroid Carcinoma in a Patient with MEN 1 Syndrome. Case Report and Literature Review
por: Friziero, Alberto, et al.
Publicado: (2020)

Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models
por: Patti, Felicia, et al.
Publicado: (2020)

Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines
por: Bertazza, Loris, et al.
Publicado: (2019)

Results and Clinical Interpretation of Germline RET Analysis in a Series of Patients with Medullary Thyroid Carcinoma: The Challenge of the Variants of Uncertain Significance
por: Innella, Giovanni, et al.
Publicado: (2020)

Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay
por: Lippi, Giuseppe, et al.
Publicado: (2020)

An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature
por: Cipri, Claudia, et al.
Publicado: (2019)

PTH: Redefining Reference Ranges in a Healthy Population—The Role of Interfering Factors and the Type of Laboratory Assay
por: Censi, Simona, et al.
Publicado: (2020)

Bactericidal/Permeability-Increasing Protein Downregulates the Inflammatory Response in In Vivo Models of Arthritis
por: Scanu, Anna, et al.
Publicado: (2022)

AHR Over-Expression in Papillary Thyroid Carcinoma: Clinical and Molecular Assessments in a Series of Italian Acromegalic Patients with a Long-Term Follow-Up
por: Mian, Caterina, et al.
Publicado: (2014)

Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT
por: Baldini, Enke, et al.
Publicado: (2011)

RET codon 609 mutations: a contribution for better clinical managing
por: Mian, Caterina, et al.
Publicado: (2012)

Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization
por: Masi, Giulia, et al.
Publicado: (2014)

Gastritis: update on etiological features and histological practical approach
por: Pennelli, Gianmaria, et al.
Publicado: (2020)

SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW
por: Plebani, Mario
Publicado: (2020)

The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System
por: Raschi, Emanuel, et al.
Publicado: (2022)

PSAT122 The Changing Face of Drug-Induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System
por: Dalmazi, Guido D, et al.
Publicado: (2022)

Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes
por: Angerilli, Valentina, et al.
Publicado: (2022)

Where Does Insulin Resistance Start?: The brain
por: Pagotto, Uberto
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_069q5jrhs184ih5petj3o0s70e